Latest Breaking News On - உயிரி தொழில்நுட்பவியல் திசையன் - Page 4 : comparemela.com

Vector Center applies for registration of its vaccine EpiVacCorona-N

Vector Center applies for registration of its vaccine EpiVacCorona-N
tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.

Rinat maksyutovResearch centerRussian health ministryState research centerBiotechnology vectorஆராய்ச்சி மையம்ரஷ்ய ஆரோக்கியம் அமைச்சகம்நிலை ஆராய்ச்சி மையம்உயிரி தொழில்நுட்பவியல் திசையன்

Russia s EpiVacCorona vaccine expected to provide immunity for one year — developer - Society & Culture

The estimates were based on research involving the first group of volunteers who had received the vaccine nine months back

Rinat maksyutovResearch centerFederation councilState research centerBiotechnology vectorDirector general rinat maksyutovஆராய்ச்சி மையம்கூட்டமைப்பு சபைநிலை ஆராய்ச்சி மையம்உயிரி தொழில்நுட்பவியல் திசையன்

Vector plans to apply to WHO for the approval of EpiVacCorona vaccine, says director

Vector plans to apply to WHO for the approval of EpiVacCorona vaccine, says director
tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.

Novosibirskaya oblastRinat maksyutovRussian state research centerWorld health organizationBiotechnology vectorDirector general rinat maksyutovKnew knowledgeரஷ்ய நிலை ஆராய்ச்சி மையம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்உயிரி தொழில்நுட்பவியல் திசையன்

Venezuela launches clinical trials of Russia s EpiVacCorona jab - World

Venezuela launches clinical trials of Russiaâs EpiVacCorona jab Acting Vice President of Venezuela Delcy Rodriguez expressed confidence that this is a good vaccine and hoped that Venezuela would be able to use it to inoculate its population Russian Ambassador to Venezuela Sergei Melik-BagdasarovÂ© Andrei Ulinkin/TASS RIO DE JANEIRO, May 5. /TASS/. Venezuela has launched clinical trials of Russia’s EpiVacCorona vaccine on Tuesday. Russian Ambassador to Venezuela Sergei Melik-Bagdasarov was the first volunteer to take part in the trials, the diplomat informed TASS. The vaccination event took place in the presence of Acting Vice President of Venezuela Delcy Rodriguez and Health Minister Carlos Alvarado.

United statesUnited kingdomSouth africaSouth africanNicolas maduroVenezolana de televisionResearch centerVenezuelan president nicolas maduroState research centerBiotechnology vectorRussian deputy prime minister yuri borisovLatin americanஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்நிக்கோலாஸ் மதுரோவேனேஜோலனா டி தொலைக்காட்சி

Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher

Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher EpiVacCorona, developed by the Russian sanitary watchdogâs State Research Center of Virology and Biotechnology Vector, is Russiaâs second coronavirus vaccine Â© Maxim Slutsky/TASS MOSCOW, May 5. /TASS/. More than 90% of people inoculated with the EpiVacCorona vaccine developed antibodies to COVID-19, Chief of the Russian State Research Center of Virology and Biotechnology Vector’s zoonotic infections and influenza department Alexander Ryzhikov said in a video posted on the Instagram page of the national sanitary watchdog on Wednesday. Independent research shows that a large part of the population is actually responding to vaccination. Earlier, we announced figures related to volunteers. At the moment, we are carrying out random research among vaccinated groups and we can see that the rate is far above 90%, he pointed out.

Bryanskaya oblastResearch centerState research centerBiotechnology vectorஆராய்ச்சி மையம்நிலை ஆராய்ச்சி மையம்உயிரி தொழில்நுட்பவியல் திசையன்